Las Pride
讚了
2
Las Pride
讚了
$BioLine Rx (BLRX.US)$ BioLineRx和Ayrmid達成授權協議，商業上稱Motixafortide（在美國以Aphexda的名義銷售），BioLineRx將收到1000萬美元的預付款，並有資格再獲得高達8700萬美元的潛在商業里程碑，再加上Aphexda凈銷售額的18%至23%的版稅。
Aphexda是Biolinerx的FDA批准的幹細胞進行動員劑，指示與filgrastim結合用於收集和隨後的自體移植...
Aphexda是Biolinerx的FDA批准的幹細胞進行動員劑，指示與filgrastim結合用於收集和隨後的自體移植...
已翻譯
3
$阿瑪琳 (AMRN.US)$ 如果價格沒有超過1美元，11月20日後將會發生什麼？
已翻譯
Las Pride
評論了
$Applied DNA Sciences (APDN.US)$ 未達最低交易價格規定的公告。需在180天內達標。公司可能很快升值至1美元，並提議進行股票逆向拆分。
已翻譯
1
2
Las Pride
評論了
已翻譯
3
5
Las Pride
評論了
$BTC Digital (BTCT.US)$ $Bitcoin Depot (BTM.US)$ $TeraWulf (WULF.US)$ $MARA Holdings (MARA.US)$ $毫微 (NA.US)$ $Nukkleus (NUKK.US)$ $MicroAlgo (MLGO.US)$ $Bit Digital (BTBT.US)$ $CleanSpark (CLSK.US)$ $Hut 8 (HUT.US)$ $Hive Blockchain (HIVE.US)$ $MicroStrategy (MSTR.US)$ $Block (SQ.US)$ $嘉楠科技 (CAN.US)$ $Genius Group (GNS.US)$ $OneMedNet (ONMD.US)$ $Next Technology (NXTT.US)$ $Semler Scientific, Inc. (SMLR.US)$ $Riot Platforms (RIOT.US)$ $Cipher Mining (CIFR.US)$ $Core Scientific (CORZ.US)$ $Greenidge Generation (GREE.US)$ $Sphere 3d (ANY.US)$ $Bitfarms (BITF.US)$ $AgriFORCE Growing (AGRI.US)$ $Solidion Technology (STI.US)$ $BTCS Inc (BTCS.US)$ $Greenidge Generation (GREE.US)$
已翻譯
29
26
Las Pride
評論了
$嘉楠科技 (CAN.US)$ 當股價達到1.78時，他們正在進行block訂單...我目前有點看淡，也許是因為他們的營業收入沒有增加或其他原因
已翻譯
1
Las Pride
讚並評論了
$嘉楠科技 (CAN.US)$ 只是留下我的評論，說著 can 在12月24日前可能上漲到7.00。
已翻譯
6
7
$中進醫療 (ZJYL.US)$ 只要他們按下去，這是正常的
已翻譯
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iMjYiIGhlaWdodD0iMjYiIHZpZXdCb3g9IjAgMCAyNiAyNiIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4KPHBhdGggZmlsbC1ydWxlPSJldmVub2RkIiBjbGlwLXJ1bGU9ImV2ZW5vZGQiIGQ9Ik0xMi45OTk5IDAuMzI1NDM5QzYuMDQxMTEgMC4zMjU0MzkgMC4zOTk5MDIgNS45NjY2NSAwLjM5OTkwMiAxMi45MjU0QzAuMzk5OTAyIDE5Ljg4NDIgNi4wNDExMSAyNS41MjU0IDEyLjk5OTkgMjUuNTI1NFYyMi43MjU0QzcuNTg3NTEgMjIuNzI1NCAzLjE5OTkgMTguMzM3OCAzLjE5OTkgMTIuOTI1NEMzLjE5OTkgNy41MTMwNSA3LjU4NzUxIDMuMTI1NDQgMTIuOTk5OSAzLjEyNTQ0VjAuMzI1NDM5WiIgZmlsbD0idXJsKCNwYWludDBfbGluZWFyXzIyMDBfNDg2NikiLz4KPHBhdGggZmlsbC1ydWxlPSJldmVub2RkIiBjbGlwLXJ1bGU9ImV2ZW5vZGQiIGQ9Ik0xMyAyNS41MjU0QzE5Ljk1ODggMjUuNTI1NCAyNS42IDE5Ljg4NDIgMjUuNiAxMi45MjU0QzI1LjYgNS45NjY2NSAxOS45NTg4IDAuMzI1NDQgMTMgMC4zMjU0MzlWMy4xMjU0NEMxOC40MTI0IDMuMTI1NDQgMjIuOCA3LjUxMzA1IDIyLjggMTIuOTI1NEMyMi44IDE4LjMzNzggMTguNDEyNCAyMi43MjU0IDEzIDIyLjcyNTRWMjUuNTI1NFoiIGZpbGw9InVybCgjcGFpbnQxX2xpbmVhcl8yMjAwXzQ4NjYpIi8+CjxjaXJjbGUgY3g9IjEzLjAwMDEiIGN5PSIyNC4xMjUzIiByPSIxLjQiIGZpbGw9InVybCgjcGFpbnQyX2xpbmVhcl8yMjAwXzQ4NjYpIi8+CjxkZWZzPgo8bGluZWFyR3JhZGllbnQgaWQ9InBhaW50MF9saW5lYXJfMjIwMF80ODY2IiB4MT0iNy4zOTk5IiB5MT0iMjUuNTI1NCIgeDI9IjcuMzk5OSIgeTI9IjIuNDI1NDQiIGdyYWRpZW50VW5pdHM9InVzZXJTcGFjZU9uVXNlIj4KPHN0b3Agc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwIi8+CjxzdG9wIG9mZnNldD0iMSIgc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwLjUiLz4KPC9saW5lYXJHcmFkaWVudD4KPGxpbmVhckdyYWRpZW50IGlkPSJwYWludDFfbGluZWFyXzIyMDBfNDg2NiIgeDE9IjIwIiB5MT0iMjUuNTI1NCIgeDI9IjIwIiB5Mj0iMi40MjU0NCIgZ3JhZGllbnRVbml0cz0idXNlclNwYWNlT25Vc2UiPgo8c3RvcCBzdG9wLWNvbG9yPSIjN0E3QTdBIi8+CjxzdG9wIG9mZnNldD0iMSIgc3RvcC1jb2xvcj0iIzdBN0E3QSIgc3RvcC1vcGFjaXR5PSIwLjUiLz4KPC9saW5lYXJHcmFkaWVudD4KPGxpbmVhckdyYWRpZW50IGlkPSJwYWludDJfbGluZWFyXzIyMDBfNDg2NiIgeDE9IjEzLjAwMDEiIHkxPSIyNC4xMjUzIiB4Mj0iMTQuNDAwMSIgeTI9IjI0LjEyNTMiIGdyYWRpZW50VW5pdHM9InVzZXJTcGFjZU9uVXNlIj4KPHN0b3Agc3RvcC1jb2xvcj0iIzdBN0E3QSIvPgo8c3RvcCBvZmZzZXQ9IjEiIHN0b3AtY29sb3I9IiM3QTdBN0EiIHN0b3Atb3BhY2l0eT0iMCIvPgo8L2xpbmVhckdyYWRpZW50Pgo8L2RlZnM+Cjwvc3ZnPgo=)